| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |